Hypopigmentation and subcutaneous fat atrophy associated with corticosteroid injection: a case report
Corticosteroid injections have been shown to be an effective treatment modality in many of the musculoskeletal and rheumatologic conditions. Yet, the potential adverse effects of corticosteroid injections have not been given much attention. One of the potential adverse effects that should be conside...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article PeerReviewed |
| Language: | English English English English |
| Published: |
Faculty of Anaesthesia, AFMS
2021
|
| Subjects: | |
| Online Access: | https://repository.unair.ac.id/117654/1/C-7%20Bukti%20Koresponding.pdf https://repository.unair.ac.id/117654/2/C-7%20Peer%20Review.pdf https://repository.unair.ac.id/117654/3/C-7%20Artikel.pdf https://repository.unair.ac.id/117654/4/C-7%20Turnitin.pdf https://repository.unair.ac.id/117654/ https://www.apicareonline.com/index.php/APIC/article/view/1708 https://doi.org/10.35975/apic.v25i6.1708 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Airlangga |
| Language: | English English English English |
| Summary: | Corticosteroid injections have been shown to be an effective treatment modality in many of the musculoskeletal and rheumatologic conditions. Yet, the potential adverse effects of corticosteroid injections have not been given much attention. One of the potential adverse effects that should be considered by clinicians is skin hypopigmentation and subcutaneous fat atrophy. Although it is a rare side effect, it may have cosmetically unpleasant effect. The aim of this case report is to highlight the importance of providing adequate information to the patients regarding these dermal adverse effects of corticosteroid injections. We report the case of a 31-year-old female who suffered from skin hypopigmentation and subcutaneous fat atrophy after triamcinolone injection given for de Quervain’s tenosynovitis. |
|---|